Qsymia (Vivus, Inc.)
Welcome to the PulseAid listing for the Qsymia drug offered from Vivus, Inc.. This Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Vivus, Inc. |
| NON-PROPRIETARY NAME: | phentermine and topiramate |
| SUBSTANCE NAME: | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-09-17 |
| END MARKETING DATE: | 0000-00-00 |
Qsymia HUMAN PRESCRIPTION DRUG Details:
| Item Description | Qsymia from Vivus, Inc. |
| LABELER NAME: | Vivus, Inc. |
| DEA SCHEDULE: | CIV
|
| ACTIVE STRENGTH: | 3.75; 23(mg/1; mg/1) |
| START MARKETING DATE: | 2012-09-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62541-201_5b49cb43-7044-3b82-e053-2a91aa0a4359 |
| PRODUCT NDC: | 62541-201 |
| APPLICATION NUMBER: | NDA022580 |
Other PHENTERMINE HYDROCHLORIDE; TOPIRAMATE Pharmaceutical Manufacturers / Labelers:
